The Library
Clinical trials impacted by the COVID-19 pandemic : adaptive designs to the rescue?
Tools
Tools
Tools
Kunz, Cornelia Ursula, Jörgens, Silke, Bretz, Frank, Stallard, Nigel, Van Lancker, Kelly, Xi, Dong, Zohar, Sarah, Gerlinger, Christoph and Friede, Tim (2020) Clinical trials impacted by the COVID-19 pandemic : adaptive designs to the rescue? Statistics in Biopharmaceutical Research . pp. 1-41. doi:10.1080/19466315.2020.1799857 (In Press)
![[img]](http://wrap.warwick.ac.uk/style/images/fileicons/application_pdf.png) |
PDF
WRAP-clinical-trials-impacted-COVID-19-pandemic-adaptive-designs-rescue-Stallard-2020.pdf - Accepted Version Embargoed item. Restricted access to Repository staff only until 22 July 2021. Contact author directly, specifying your specific needs. - Requires a PDF viewer. Download (1123Kb) |
Official URL: http://dx.doi.org/10.1080/19466315.2020.1799857
Abstract
Very recently the new pathogen severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was identified and the coronavirus disease 2019 (COVID-19) declared a pandemic by the World Health Organization. The pandemic has a number of consequences for ongoing clinical trials in non-COVID-19 conditions. Motivated by four current clinical trials in a variety of disease areas we illustrate the challenges faced by the pandemic and sketch out possible solutions including adaptive designs. Guidance is provided on (i) where blinded adaptations can help; (ii) how to achieve type I error rate control, if required; (iii) how to deal with potential treatment effect heterogeneity; (iv) how to utilize early read-outs; and (v) how to utilize Bayesian techniques. In more detail approaches to resizing a trial affected by the pandemic are developed including considerations to stop a trial early, the use of group-sequential designs or sample size adjustment. All methods considered are implemented in a freely available R shiny app. Furthermore, regulatory and operational issues including the role of data monitoring committees are discussed.
| Item Type: | Journal Article | ||||||
|---|---|---|---|---|---|---|---|
| Subjects: | Q Science > QH Natural history Q Science > QR Microbiology R Medicine > R Medicine (General) R Medicine > RA Public aspects of medicine |
||||||
| Divisions: | Faculty of Medicine > Warwick Medical School > Health Sciences Faculty of Medicine > Warwick Medical School > Health Sciences > Statistics and Epidemiology Faculty of Medicine > Warwick Medical School |
||||||
| Library of Congress Subject Headings (LCSH): | COVID-19 (Disease), Biodiversity, Pathogenic microorganisms, Clinical trials | ||||||
| Journal or Publication Title: | Statistics in Biopharmaceutical Research | ||||||
| Publisher: | Routledge | ||||||
| ISSN: | 1946-6315 | ||||||
| Official Date: | 22 July 2020 | ||||||
| Dates: |
|
||||||
| Date of first compliant deposit: | 5 August 2020 | ||||||
| Page Range: | pp. 1-41 | ||||||
| DOI: | 10.1080/19466315.2020.1799857 | ||||||
| Status: | Peer Reviewed | ||||||
| Publication Status: | In Press | ||||||
| Publisher Statement: | This is an Accepted Manuscript of an article published by Taylor & Francis in Statistics in Biopharmaceutical Research on 22 Jul 2020, available online: http://www.tandfonline.com/10.1080/19466315.2020.1799857 | ||||||
| Access rights to Published version: | Restricted or Subscription Access | ||||||
| RIOXX Funder/Project Grant: |
|
Request changes or add full text files to a record
Repository staff actions (login required)
 |
View Item |
